- Country: UAE
- Summary: Vaccine Foot and Mouth Disease Aftovac 3ml - 18,000 Ea
- AET Ref No: 115388770
- Deadline: 05 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: tender_213169
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Opportunity Description : 1: [520-17987] VACCINE FOOT AND MOUTH DISEASE AFTOVAC 3ML - 18,000 EA
2: [520-21667] LAXATIVE POWDER (MAGNESIUM CARBONATE-SODIUM CARBONATE-NUX VOMICA)100/101 GM - 800 EA
3: [520-01819] INTRAVENOUS INFUSION SET - 500 EA
4: [520-20599] UDDERINE OINTMENT 200GRM - 60 BTL
5: [520-20777] EXAMINATION GLOVES 5 FINGERS, LONG MODEL EICKEMEYER SUPER SENSITIVE STRONG 100/BOX 27X13X6 CM - 60 BX
6: [520-19453] INJECTION AMOXICILLIN 15%L.A.-100ML - 150 BTL
7: [520-20448] BIOFEL M PLUS, INACTIVATED VACCINE AGAINST MICROSPORUM CANIS, BIOVETA. 10X1 DOSE - 20 EA - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINVaccine Foot and Mouth Disease Aftovac 3ml - 18,000 Ea - UAE Tender
The DUBAI MUNICIPALITY, a Government sector organization in UAE, has announced a new tender for Vaccine Foot and Mouth Disease Aftovac 3ml - 18,000 Ea. This tender is published on UAETenders under AET Ref No: 115388770 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
